AngioDynamics, Inc. is a healthcare company based in the United States, specializing in the design, manufacturing, and sale of medical devices for the treatment of peripheral vascular disease, oncology, and surgical purposes. The company has a medium risk rating score of 29.0. AngioDynamics generates most of its revenue from Endovascular Therapies in the United States. With a focus on ESG practices, AngioDynamics aims to provide sustainable and environmentally-friendly healthcare solutions.